Article

Nonventilatory strategies for patients with life-threatening 2009 H1N1 influenza and severe respiratory failure

Department of Surgery, University of Michigan Health System, Ann Arbor, MI, USA.
Critical care medicine (Impact Factor: 6.15). 04/2010; 38(4 Suppl):e74-90. DOI: 10.1097/CCM.0b013e3181cc5373
Source: PubMed

ABSTRACT Severe respiratory failure (including acute lung injury and acute respiratory distress syndrome) caused by 2009 H1N1 influenza infection has been reported worldwide. Refractory hypoxemia is a common finding in these patients and can be challenging to manage. This review focuses on nonventilatory strategies in the advanced treatment of severe respiratory failure and refractory hypoxemia such as that seen in patients with severe acute respiratory distress syndrome attributable to 2009 H1N1 influenza. Specific modalities covered include conservative fluid management, prone positioning, inhaled nitric oxide, inhaled vasodilatory prostaglandins, and extracorporeal membrane oxygenation and life support. Pharmacologic strategies (including steroids) investigated for the treatment of severe respiratory failure are also reviewed.

1 Follower
 · 
163 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Technical complications are a known hazard in veno-venous extracorporeal membrane oxygenation (vvECMO). Identifying these complications and predictive factors indicating a developing system-exchange was the goal of the study. Retrospective study on prospectively collected data of technical complications including 265 adult patients (Regensburg ECMO Registry, 2009-2013) with acute respiratory failure treated with vvECMO. Alterations in blood flow resistance, gas transfer capability, hemolysis, coagulation and hemostasis parameters were evaluated in conjunction with a system-exchange in all patients with at least one exchange (n = 83). Values presented as median (interquartile range). Patient age was 50(36-60) years, the SOFA score 11(8-14.3) and the Murray lung injury Score 3.33(3.3-3.7). Cumulative ECMO support time 3411 days, 9(6-15) days per patient. Mechanical failure of the blood pump (n = 5), MO (n = 2) or cannula (n = 1) accounted for 10% of the exchanges. Acute clot formation within the pump head (visible clots, increase in plasma free hemoglobin (frHb), serum lactate dehydrogenase (LDH), n = 13) and MO (increase in pressure drop across the MO, n = 16) required an urgent system-exchange, of which nearly 50% could be foreseen by measuring the parameters mentioned below. Reasons for an elective system-exchange were worsening of gas transfer capability (n = 10) and device-related coagulation disorders (n = 32), either local fibrinolysis in the MO due to clot formation (increased D-dimers [DD]), decreased platelet count; n = 24), or device-induced hyperfibrinolysis (increased DD, decreased fibrinogen [FG], decreased platelet count, diffuse bleeding tendency; n = 8), which could be reversed after system-exchange. Four MOs were exchanged due to suspicion of infection. The majority of ECMO system-exchanges could be predicted by regular inspection of the complete ECMO circuit, evaluation of gas exchange, pressure drop across the MO and laboratory parameters (DD, FG, platelets, LDH, frHb). These parameters should be monitored in the daily routine to reduce the risk of unexpected ECMO failure.
    PLoS ONE 12/2014; 9(12):e112316. DOI:10.1371/journal.pone.0112316 · 3.53 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: L’objectif de cette revue est d’examiner les indications des membranes d’oxygénation extracorporelle (ECMO) lors d’un syndrome de détresse respiratoire aiguë (SDRA). Le recours à cette technique d’oxygénation a augmenté de manière significative à travers le monde depuis la pandémie grippale H1N1. Le but de l’ECMO est de maintenir un niveau acceptable d’oxygénation, ainsi que de contrôler l’acidose respiratoire sous ventilation protectrice. Cet enthousiasme pour l’ECMO ne doit pas faire négliger les complications potentielles associées à la technique. Avant d’élargir le recours à l’ECMO, de nouvelles études devront tester l’efficacité d’une utilisation précoce ou d’une épuration du CO2 en complément ou à la place de la ventilation mécanique lors d’un SDRA sévère.
    Annales francaises d'anesthesie et de reanimation 07/2014; 33(7-8). DOI:10.1016/j.annfar.2014.07.008 · 0.84 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In this article, summary data from the annual international Extracorporeal Life Support Organization (ELSO) Registry Reports through July 2012 are presented. Nearly 51,000 patients have received extracorporeal life support (ECLS). Of the patients, 50% (>25,000) were neonatal respiratory failure, with a 75% overall survival to discharge or transfer. Congenital diaphragmatic hernia remains a major use of ECLS in this population with 51% survival. Extracorporeal life support use for pediatric respiratory failure has nearly doubled since 2000, with approximately 350 patients treated per year in the past 3 years examined (56% survival). Previously stable at about 100 cases a year for a decade, adult respiratory failure ECLS cases increased dramatically in 2009 with the H1N1 influenza pandemic and publication of the Conventional ventilation or ECMO for Severe Adult Respiratory failure (CESAR) trial results and have remained at approximately 400 cases a year through 2011 (55% survival). Use of ECLS for cardiac support represents a large area of consistent growth. Approximately 13,000 patients have been treated with survival to discharge rates of 40%, 49%, and 39% for neonates, pediatric, and adults, respectively.
    ASAIO journal (American Society for Artificial Internal Organs: 1992) 05/2013; 59(3):202-10. DOI:10.1097/MAT.0b013e3182904a52 · 1.39 Impact Factor

Preview

Download
5 Downloads
Available from